Serine/threonine protein kinase 25 antisense oligonucleotide treatment reverses glucose intolerance, insulin resistance, and nonalcoholic fatty liver disease in mice.

about

Serine/threonine protein kinase 25 antisense oligonucleotide treatment reverses glucose intolerance, insulin resistance, and nonalcoholic fatty liver disease in mice.

Item

http://www.wikidata.org/entity/Q52384622

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Serine/threonine protein kinas ...... c fatty liver disease in mice.

@en

Serine/threonine protein kinas ...... c fatty liver disease in mice.

@nl

type

Item

label

Serine/threonine protein kinas ...... c fatty liver disease in mice.

@en

Serine/threonine protein kinas ...... c fatty liver disease in mice.

@nl

prefLabel

Serine/threonine protein kinas ...... c fatty liver disease in mice.

@en

Serine/threonine protein kinas ...... c fatty liver disease in mice.

@nl

P1476

Serine/threonine protein kinas ...... c fatty liver disease in mice.

@en

P2093

Andrew Watt

http://www.w3.org/2001/XMLSchema#string

Emmelie Cansby

http://www.w3.org/2001/XMLSchema#string

Esther Nuñez-Durán

http://www.w3.org/2001/XMLSchema#string

Hanns-Ulrich Marschall

http://www.w3.org/2001/XMLSchema#string

Mariam Aghajan

http://www.w3.org/2001/XMLSchema#string

Sheri L Booten

http://www.w3.org/2001/XMLSchema#string

Silva Sütt

http://www.w3.org/2001/XMLSchema#string

P2860

Liver-specific beta-catenin knockout mice exhibit defective bile acid and cholesterol homeostasis and increased susceptibility to diet-induced steatohepatitis

MST kinases in development and disease

Acetyl coenzyme A: a central metabolite and second messenger

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

Nonalcoholic fatty liver disease: a systematic review

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening.

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin.

RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform.

P304

69-83

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP4.1128

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-11-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29404514

http://www.w3.org/2001/XMLSchema#string

P932

5776874

http://www.w3.org/2001/XMLSchema#string